This series adds to a growing body of literature that demonstrates that robot-assisted
radical cystectomy (RARC) with extracorporeal urinary diversion and complete pelvic
lymph node dissection can be performed by experienced surgeons with acceptable outcomes.
Although this is a single surgeon series, it is robust in terms of numbers (N = 175),
median follow-up (37 months), use of neoadjuvant chemotherapy (22%), and the consecutive
nature of patient inclusion helping to mitigate the selection bias that detracts from
most nonrandomized series. The results suggest, as other studies have also shown,
a general noninferiority of RARC when compared with open radical cystectomy (ORC).
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to UrologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
